Absorption characteristics of macromolecular prodrugs of mitomycin C following intramuscular administration.
- 1 January 1986
- journal article
- research article
- Published by Pharmaceutical Society of Japan in CHEMICAL & PHARMACEUTICAL BULLETIN
- Vol. 34 (4) , 1775-1783
- https://doi.org/10.1248/cpb.34.1775
Abstract
The absorption characteristics of several kinds of macromolecular compounds following intramuscular injection were studied in rats. Three types of 14C-labeled mitomycin C-dextran conjugates (14C-MMC-D), bare 14C-dextran, 14C-inulin, and 131I-albumin were used, and their absorption and subsequent lymphatic uptake were determined by radioactivity counting. Clearance of cationic 14C-MMC-D from the injection site was slow and varied with the molecular weight. Remarkable accumulation of radioactivity was observed in the regional lymph node after injection of 14C-MMC-D. Bare 14C-dextran showed similar behavior, but the rate of clearance was faster and less accumulation in the lymph node was observed compared with 14C-MMC-D of the same molecular weight. In contrast 14C-inulin and 131I-albumin showed rapid disappearance from the muscle and no accumulation in the lymph node. Muscular absorption data were fitted to a compartment model including a Langmuir-type adsorption. Pharmacokinetic analysis revealed that the rate of absorption and the degree of adsorption depended on the molecular weight and electric charge, and MMC-D with a molecular weight of 500000 proved to have the longest period of residence. Thus, it was elucidated that physicochemical properties, such as molecular weight and electric charge, affect the pharmacokinetic behavior of macromolecular compounds injected topically.This publication has 10 references indexed in Scilit:
- DISPOSITION AND PHARMACOKINETICS OF A POLYMERIC PRODRUG OF MITOMYCIN-C, MITOMYCIN-C-DEXTRAN CONJUGATE, IN THE RAT1984
- ENHANCED LYMPHATIC DELIVERY OF MITOMYCIN-C CONJUGATED WITH DEXTRAN1984
- Regeneration characteristics of mitomycin C-dextran conjugate in relation to its activity.CHEMICAL & PHARMACEUTICAL BULLETIN, 1983
- Physico-chemical and antitumor characteristics of high molecular weight prodrugs of Mitomycin C.CHEMICAL & PHARMACEUTICAL BULLETIN, 1982
- A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studies.Proceedings of the National Academy of Sciences, 1982
- Mitomycin C-dextran conjugate: a novel high molecular weight pro-drug of mitomycin CJournal of Pharmacy and Pharmacology, 1980
- PREFERENTIAL ACTIVATION OF MITOMYCIN-C TO CYTO-TOXIC METABOLITES BY HYPOXIC TUMOR-CELLS1980
- LETHAL AND CYTOKINETIC EFFECTS OF MITOMYCIN-C ON CULTURED HUMAN-COLON CANCER-CELLS1980
- Biopharmaceutical Considerations in Subcutaneous and Intramuscular Drug AdministrationJournal of Pharmaceutical Sciences, 1968
- A simplified method of sample preparation for determination of tritium, carbon-14, or sulfur-35 in blood or tissue by liquid scintillation countingAnalytical Biochemistry, 1966